Choosing a dermatologist in the UK can feel unexpectedly opaque. Consultant titles, NHS affiliations, private clinics and subspecialist services are often presented as though they are interchangeable, when in reality they reflect different stages of training, different scopes of practice and different clinical environments.
A common assumption is that all consultant dermatologists are trained to the same depth across every area of the specialty, or that private dermatology represents a cosmetic extension of NHS work. Neither assumption is accurate. Dermatology is a broad medical specialty and, like most areas of medicine, expertise develops through subspecialisation rather than during core training alone.
Many people searching for a dermatologist are doing so because they have been living with a visible, persistent or emotionally burdensome skin problem, and are uncertain where to turn next. Understanding how dermatologists are trained, what the NHS is designed to deliver, and how subspecialist expertise develops allows patients to make informed choices without relying on titles alone.
This article is written by a UK consultant dermatologist who trained and practised within the NHS for over a decade, qualifying as a consultant in 2013, before moving into full-time private practice. Having worked across both systems and having taught and examined within UK dermatology, it reflects how dermatology actually functions in practice rather than how it is often presented.
Dermatology training in the UK
The pathway to becoming a consultant dermatologist in the UK is standardised, tightly regulated and extremely competitive. Entry into specialist training requires broad medical experience and success at national selection. Progression through training involves years of structured assessment across medical, surgical and diagnostic dermatology, alongside completion of a national written exit examination.
All consultants have come through essentially the same route. Differences in expertise do not arise because some dermatologists have had easier training or lower standards. They arise through subspecialisation, additional training and experience. Consultant status represents a rigorous baseline, not uniform expertise across every domain of dermatology.
Core dermatology training focuses on medical dermatology. Consultants are trained to diagnose and manage inflammatory skin disease, recognise skin cancer and pre-cancerous lesions, assess complex rashes and identify cutaneous signs of systemic illness. They are trained to work diagnostically, to assess risk and to collaborate with other specialties when required. This diagnostic breadth is one of the strengths of NHS dermatology.
Subspecialisation within NHS training
Some subspecialisation takes place within NHS training, usually through formal fellowships or additional training years. These pathways are designed to meet NHS service needs and are embedded within recognised training structures. Examples include additional training in Mohs micrographic surgery, paediatric dermatology, cutaneous lymphoma, complex skin cancer and other tertiary referral services. These fellowships are competitive, structured and focused on conditions that sit squarely within NHS provision. They often involve an additional year of training and lead to clearly defined subspecialist roles.
This form of subspecialisation reflects the conditions the NHS is commissioned to diagnose and treat, and it allows patients with complex or rare diseases to be managed within established multidisciplinary frameworks.
What is not covered within NHS training?
Because the NHS is a publicly funded healthcare system, training priorities align with disease management, cancer care and the prevention of serious morbidity. As a result, areas such as cosmetic dermatology, aesthetic procedures and advanced procedural dermatology do not form part of formal NHS subspecialty training pathways.
Within training, these areas are therefore covered at a foundational, knowledge-based level. Trainees are expected to understand indications, contraindications and theoretical risks. This knowledge is assessed primarily through written examinations and limited structured teaching. It is sufficient to recognise when a treatment may or may not be appropriate, but it does not confer independent procedural expertise.
In practical terms, many dermatology trainees will qualify as consultants having had little or no opportunity to personally deliver advanced cosmetic or procedural treatments. Exposure is often observational or theoretical, adequate for examinations but not for developing procedural judgement. This is a structural feature of training rather than a reflection of individual ability.
How cosmetic and procedural subspecialisation develops
For dermatologists who choose to practise in cosmetic or procedural fields, subspecialisation usually develops after completion of general training. This mirrors how expertise develops in many procedural areas of medicine that sit outside core NHS provision.
Post-CCT subspecialisation (i.e. additional specific training after consultancy) typically involves additional courses, mentorship, fellowships or preceptorships, followed by years of regular clinical practice. Competence develops through repetition, management of complications and longitudinal follow-up, not through short courses alone.
This type of expertise is therefore highly practitioner-specific. It cannot be assumed from consultant status alone and varies depending on the individual’s training choices and clinical volume over time.
In procedural and subspecialist areas of dermatology, volume matters. Clinicians who see the same types of concerns repeatedly develop a deeper understanding of variation, edge cases and complications. They learn when an outcome falls within expected limits, when caution is required and when a different approach is needed. Long-term follow-up is equally important, as it allows outcomes to be assessed beyond the immediate result.
This degree of judgement cannot be replicated through occasional practice or theoretical knowledge alone. It develops gradually, through exposure and responsibility, and is one of the reasons consultant expertise is not interchangeable even when formal qualifications appear similar.
Why the subspecialist focus should be coherent
In most areas of medicine, subspecialisation is intuitively understood. Patients would not expect the interventional cardiologist who performed their coronary stent to manage complex lipid disorders, nor a heart failure specialist to undertake electrophysiology procedures. Expertise is contextual and built within defined domains.
Dermatology is no different. A dermatologist’s subspecialist focus within the NHS should logically align with the care they offer privately. A clinician whose NHS work centres on skin cancer surgery may not be best placed to deliver complex procedural dermatology, just as a dermatologist who has subspecialised in cosmetic procedures would not claim expertise in Mohs surgery or tertiary skin cancer care.
In medicine, knowing the limits of one’s expertise is as important as knowing its strengths. For patients, coherence between training focus and clinical practice is a more meaningful indicator of expertise than title alone.
When is NHS dermatology the right place to be treated?
This distinction is not about superiority. It is about suitability. Patients with complex dermatological disease involving multiple organ systems, those requiring repeated biopsies, or those whose care depends on coordinated input from rheumatology, histopathology, plastic surgery or oncology are often best served within the NHS. Multidisciplinary teams are well established, access to cross-specialty opinion is straightforward and escalation pathways are clear.
For skin cancer and complex medical dermatology, NHS dermatology services are frequently the optimal environment.
Why cosmetic and procedural dermatology sit outside the NHS
Cosmetic dermatology and aesthetic procedures are not commissioned NHS services. They sit outside NHS pathways by design. Public healthcare systems must prioritise interventions that address disease, reduce mortality or prevent serious morbidity.
As a result, patients seeking treatment for concerns such as acne scarring, pigmentation, redness or skin texture will inevitably be seen privately. This is not a reflection of legitimacy or value. It is a function of the system remit. The relevant question for patients is therefore not whether private care is appropriate, but whether the clinician providing it has the relevant subspecialist training, experience and governance.
Variation in private dermatology fees reflects differences in training, subspecialisation, clinical volume, governance, location and scope of consultation. One of the most common questions patients ask is why private dermatology fees vary so widely. It is often assumed that cost reflects time spent, location or branding. In reality, time is only a small part of the equation.
What patients are primarily paying for is experience. An experienced clinician can often make a complex problem appear straightforward because they have seen similar cases many times before. Pattern recognition develops through repetition. Over time, this allows unnecessary investigations to be avoided, risks to be identified earlier and decisions to be made with greater confidence.
What feels efficient to the patient is often the product of years of accumulated judgment. A shorter consultation with the right person can be more valuable than a longer one with someone who is still working through the possibilities.
Fees also reflect responsibility. Private consultants carry full accountability for diagnostic decisions, prescribing choices, follow-up planning and outcome management. Service infrastructure also matters. Continuity of care, access to review, governance processes and the ability to manage complications all require systems and experience behind the scenes.
Price, therefore, is not a proxy for exclusivity. It is a reflection of expertise, responsibility and the structure required to deliver consistent care.
What consultant-led care actually means
Patients often encounter the term consultant-led without it being clearly explained. In practice, consultant-led care means that a consultant dermatologist sets clinical standards, establishes protocols, oversees diagnosis and treatment decisions, and remains responsible for escalation and outcomes.
This does not mean that every element of care must be delivered personally by the consultant. In both NHS and private settings, appropriately trained clinicians work within consultant-led frameworks. This model allows care to be delivered safely, consistently and efficiently, while ensuring that complex decisions remain under senior clinical oversight.
Understanding this distinction helps patients interpret who is delivering their care and how responsibility is structured, rather than assuming that quality depends solely on who performs each individual step.
Governance, regulation and oversight
High-quality dermatology care does not depend solely on the seniority of the individual delivering each element of treatment. It depends on governance: clear protocols, defined escalation pathways and appropriate clinical oversight.
In private practice, clinicians remain accountable to the same professional regulators as they do within the NHS, including the General Medical Council, and are expected to practise within established standards of clinical governance regardless of setting.
Experienced GPs with dermatology expertise and specialist practitioners play an important role in modern dermatology services. When they work within consultant-led frameworks, with diagnostic oversight and access to escalation when required, care can be safe and effective. This mirrors NHS practice, where consultants lead services rather than delivering every aspect personally.
Off-licence prescribing and senior judgement
Another difference between NHS and private dermatology lies in the use of off-licence medications. NHS practice is guided by NICE recommendations and commissioning policies, which evolve cautiously. Evidence often develops more quickly than guidelines.
In private practice, experienced clinicians may prescribe medications outside their formal licence when there is a sound evidence base, informed consent and appropriate monitoring. This is recognised medical practice and supported by GMC guidance. In dermatology, examples include spironolactone for adult female acne and clonidine for flushing in rosacea.
Such prescribing requires experience, confidence with risk and willingness to take responsibility for outcomes. It is not appropriate in poorly governed or inexperienced settings.
Applying this in practice: choosing the right dermatologist
Patients often ask how to apply this information when deciding who to see. A helpful starting point is to consider the nature of the problem rather than focusing on job titles alone.
Conditions involving complex inflammatory disease, multisystem involvement, repeated biopsies or suspected skin cancer are often best managed within the NHS or by consultants whose practice centres on these areas. Paediatric skin disease is best assessed by clinicians with dedicated experience in children. Hair disorders benefit from assessment by dermatologists who routinely manage hair and scalp conditions rather than encountering them occasionally.
Procedural and cosmetic concerns are different. These require clinicians who have deliberately subspecialised after qualification and who practise within that field regularly. In these settings, experience, volume and outcome review matter more than generalist exposure.
It is reasonable for patients to ask about experience, focus and the types of cases a clinician sees most often. Understanding how closely a clinician’s day-to-day practice aligns with a particular concern is often more informative than relying on titles alone. Patients are entitled to ask about training, experience and professional registration. The GMC register is publicly accessible and provides information about specialist status.
This article is intended to explain how dermatology training and practice are structured in the UK, and why expertise varies within the specialty. It is not a guide to individual clinicians, nor does it replace personalised medical advice.
Training pathways describe foundations rather than outcomes. Individual judgement, experience and focus develop over time and differ between clinicians. The purpose of this discussion is to provide a framework for understanding the system, rather than a set of rules.
Much of the confusion around NHS and private dermatology arises from the assumption that one system must be better than the other. In reality, they are designed to do different things. The NHS excels at complex, multidisciplinary care. Private practice allows time, flexibility and subspecialist focus in areas the NHS is not commissioned to provide. Understanding this distinction allows patients to navigate dermatology services with clarity rather than assumption.
